SFU Library Licensed Material

Access to the content in this collection is restricted to current SFU faculty, students, and staff.

This collection contains various types of content licensed by the SFU Library on behalf of the University. 

Copyright and Terms of use

This work is protected by copyright in Canada unless its copyright has expired. The user is responsible for doing their own assessment. 

You may use this work as permitted by applicable licenses, fair dealing and other exceptions under copyright legislation in your jurisdiction. For guidance on seeking further permissions, contact the source/owner of the material.

Search within Collection

Displaying 451 - 465 of 710

The Cardiovascular Market Outlook to 2016,Datamonitor report

BI00042-007-Thumbnail Image.png
Date: 2011-06-13
Description: This report provides a comprehensive coverage of the cardiovascular market, incorporating epidemiological analyses of major indications, assessment of the marketed product portfolio and R&D pipeline, and competitive dynamics of leading players.

The Changing Role of Natural Products in Drug Discovery,Datamonitor report

BI00040-006-Thumbnail Image.png
Date: 2011-07-04
Name(s): Norman, Peter
Description: Natural products remain an underexploited resource despite their historical success in providing valuable drugs. They offer access to novel areas of biologically relevant chemical space, and may help address the industry's innovation challenge.

The CMO Market Outlook to 2017,Datamonitor report

BI00046-007-Thumbnail Image.png
Date: 2012-02-17
Name(s): Sahoo, Alison
Description: A weak economy combined with increasingly uncertain regulatory and payer environments are driving pharma companies to cut internal manufacturing, creating a strong contract manufacturing market. Emerging regions will account for the greatest growth.

The CMO Market Outlook,Datamonitor report

BI00025-016-Thumbnail Image.png
Date: 2009-11-04
Name(s): Green, G. C.
Description: Falling productivity and patent expiries are placing increasing pressure on pharmaceutical companies to reduce fix costs. Sponsors are turning to CMOs in search of time and cost savings and as a way to flexibly manage outsourced manufacturing.

The CNS Market Outlook to 2016,Datamonitor report

BI00042-011-Thumbnail Image.png
Date: 2011-07-13
Description: CNS disorders have high prevalence across all markets and consequently represent a large market estimated to be over $70bn in 2010. Patent expiries will cause a market contraction to 2016.

The Community of the School

sfulibr_1700-Thumbnail Image.png

The Computed and Digital Radiography Market to 2016 in Europe and the US,Datamonitor report

BI00043-005-Thumbnail Image.png
Date: 2011-08-25
Name(s): Shanmugham, Shriram
Description: The purchase of DR systems has increased in recent years despite the fact that DR systems cost nearly three times the price of CR systems. This report assesses the reason for such adoption and evaluates the DR/CR market size in the US and Europe.

The Computed Tomography (CT) Market Outlook to 2016,Datamonitor report

BI00043-010-Thumbnail Image.png
Date: 2011-08-26
Name(s): Bhattacharjee, Krishanu
Description: Adequate installed base in the developed markets such as the US and Europe has made revenue growth highly dependent on replacement of existing units. CT scanner vendors are now looking at sustaining their revenue growth by looking eastwards.

The Contract Sales Organization (CSO) Market Outlook to 2015,Datamonitor report

BI00025-020-Thumbnail Image.png
Date: 2010-06-15
Name(s): Green, G. C.
Description: The Contract Sales Organization (CSO) Market Outlook provides a detailed analysis of the demands on CSOs in the evolving pharmaceutical sales and marketing environment. Outsourcing is growing as the industry seeks to reduce fixed costs.

The Convergence of Biomarkers and Diagnostics,Datamonitor report

BI00020-012-Thumbnail Image.png
Date: 2008-04-08
Description: Understanding of disease heterogeneity has stimulated demand for increased precision in disease diagnosis and monitoring. Biomarkers are key tools to characterize disease and treatment responses at the DNA, RNA, protein, or metabolite levels.

The Cost of Power Generation,Datamonitor report

BI00016-024-Thumbnail Image.png
Date: 2010-05-17
Name(s): Breeze, Paul
Description: Since the publication by Business Insights of the last report into the cost of electricity there has been a massive change in global economic conditions as a result of the ramifications of the 2008 banking crisis.

The Cost of Power Generation,Datamonitor report

BI00016-008-Thumbnail Image.png
Date: 2008-05-07
Name(s): Breeze, Paul
Description: The debate about the economic and environmental benefits of renewable power generation technologies remains high on the agenda.

The CRO Market Outlook To 2014,Datamonitor report

BI00025-015-Thumbnail Image.png
Date: 2009-08-27
Name(s): Green, G. C.
Description: This fully updated CRO Market Outlook assesses market drivers and resistors and their effects. The report analyzes industry trends; examines multiple regions; evaluates the leading CROs; and outlines the future of the industry.

The CRO Market Outlook to 2016,Datamonitor report

BI00046-006-Thumbnail Image.png
Date: 2011-11-18
Name(s): Sahoo, Alison
Description: The CRO market continues to undergo strong growth despite a soft economy and ongoing pressures on drug developers. The industry is evolving through mergers and acquisitions and changing contracting and relationship models.

The Dermatology Market Outlook to 2016,Datamonitor report

BI00042-013-Thumbnail Image.png
Date: 2011-07-12
Description: Dermatological conditions have high prevalence across all markets and consequently represent a large market which Scrip Business Insights values at $17bn. New products responding to areas of unmet need are driving considerable sales growth.